A. Valantine Hannah, Director: BridgeBio Pharma BBIO Planned sale · Filed 25/03/06

Trade details

Type: Planned sale notice
Stock: BridgeBio Pharma BBIO
Person: A. Valantine HannahDirector
Planned sale date: 25/03/06
Filed: 25/03/06

$419.5K to be sold

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 25/02/04~25/04/05

A. Valantine Hannah's recent trades

Hannah ValantineDirector
Planned sale10b5-1 planCareDx
Planned sale10b5-1 plan
CareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
Hannah ValantineDirector
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
Hannah ValantineDirector
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22

A. Valantine Hannah, Director — plans to sell 12,875 sh of BridgeBio Pharma BBIO · $419.5K · around 03/06 · 10b5-1 plan | Whalegun